Serum autotaxin as a novel prognostic marker in patients with non‐ischaemic dilated cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13817
Abstract: Autotaxin (ATX) promotes myocardial inflammation, fibrosis, and the subsequent cardiac remodelling through lysophosphatidic acid production. However, the prognostic impact of serum ATX in non‐ischaemic dilated cardiomyopathy (NIDCM) has not been clarified. We investigated the prognostic… read more here.
Keywords: ischaemic dilated; dilated cardiomyopathy; serum autotaxin; non ischaemic ... See more keywords
Treatment response in recent‐onset heart failure with reduced ejection fraction: non‐ischaemic vs. ischaemic aetiology
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14214
Abstract: In heart failure (HF) with reduced left ventricular ejection fraction (HFrEF), the prognosis appears better in non‐ischaemic than in ischaemic aetiology. Infrequent diagnostic work‐up for ischaemic heart disease (IHD) in HF is reported. In this… read more here.
Keywords: heart failure; non ischaemic; failure reduced; heart ... See more keywords
Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non‐ischaemic heart failure
Sign Up to like & getrecommendations! Published in 2023 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14293
Abstract: A causal link between non‐ischaemic heart failure (HF) and humoral autoimmunity against G‐protein‐coupled receptors (GPCR) remains unclear except for Chagas' cardiomyopathy. Uncertainty arises from ambiguous reports on incidences of GPCR autoantibodies, spurious correlations of autoantibody… read more here.
Keywords: non ischaemic; heart failure; histology; ischaemic heart ... See more keywords
Transient versus persistent improved ejection fraction in non‐ischaemic dilated cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2512
Abstract: The recent definition of heart failure with improved ejection fraction outlined the importance of the longitudinal assessment of left ventricular ejection fraction (LVEF). However, long‐term progression and outcomes of this subgroup are poorly explored. We… read more here.
Keywords: ischaemic dilated; improved ejection; non ischaemic; ejection ... See more keywords
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2514
Abstract: Genotype and left ventricular scar on cardiac magnetic resonance (CMR) are increasingly recognized as risk markers for adverse outcomes in non‐ischaemic dilated cardiomyopathy (DCM). We investigated the combined influence of genotype and late gadolinium enhancement… read more here.
Keywords: ischaemic dilated; non ischaemic; late gadolinium; genotype ... See more keywords
Should we rethink the indications for implantable cardioverter‐defibrillators in non‐ischaemic dilated cardiomyopathy?
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.948
Abstract: Heart failure (HF) represents a major cause of morbidity and health care expenditure globally,1 and increases the risk for sudden cardiac death (SCD). In the USA, about 325 000 adults die from SCD every year,… read more here.
Keywords: heart failure; scd; non ischaemic; icd implantation ... See more keywords
Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2019 at "Current Cardiology Reports"
DOI: 10.1007/s11886-019-1236-3
Abstract: Non-ischaemic dilated cardiomyopathy (DCM) occurs in 1 in 2500 individuals in the general population and is associated with considerable morbidity and mortality. Studies involving large numbers of unselected DCM patients have led to consensus guidelines… read more here.
Keywords: risk; ischaemic dilated; risk stratification; scd ... See more keywords
Relationship between serum chloride and prognosis in non-ischaemic dilated cardiomyopathy: a large retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-067061
Abstract: Objectives Serum chloride has a unique homeostatic role in modulating neurohormonal pathways. Some studies have reported that hypochloremia has potential prognostic value in cardiovascular diseases; thus, we aimed to investigate the association of baseline serum… read more here.
Keywords: ischaemic dilated; non ischaemic; serum chloride; study ... See more keywords
15 Non-ischaemic cardiomyopathy and cardiac resynchronization therapy– revisiting the ‘at risk’ patient profile
Sign Up to like & getrecommendations! Published in 2018 at "Heart"
DOI: 10.1136/heartjnl-2018-ics.15
Abstract: Background Non-ischaemic cardiomyopathy has been associated with better left ventricular (LV) remodeling and outcomes post-cardiac resynchonization therapy (CRT) but has separately been linked to poorer outcomes when associated with mid-wall fibrosis (MWF) on cardiac magnetic… read more here.
Keywords: mwf; ischaemic cardiomyopathy; non ischaemic; therapy ... See more keywords
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction
Sign Up to like & getrecommendations! Published in 2020 at "Heart"
DOI: 10.1136/heartjnl-2019-315942
Abstract: Sudden cardiac death and arrhythmia-related events in patients with non-ischaemic dilated cardiomyopathy (NICM) have been significantly reduced over the last couple of decades as a result of evidence-based pharmacological and non-pharmacological therapeutic strategies. Nevertheless, the… read more here.
Keywords: risk; ischaemic dilated; risk stratification; arrhythmic risk ... See more keywords